Detalles de la búsqueda
1.
Maintenance therapy with vinflunine plus best supportive care versus best supportive care alone in patients with advanced urothelial carcinoma with a response after first-line chemotherapy (MAJA; SOGUG 2011/02): a multicentre, randomised, controlled, open-label, phase 2 trial.
Lancet Oncol
; 18(5): 672-681a, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28389316
2.
The Wide Experience of the Sequential Therapy for Patients with Metastatic Renal Cell Carcinoma.
Curr Oncol Rep
; 18(11): 66, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27613167
3.
Metastatic Bladder Cancer: Second-Line Treatment and Recommendations of the Genitourinary Tumor Division of the Galician Oncologic Society (SOG-GU).
Curr Oncol Rep
; 18(12): 72, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27812861
4.
Clinical Application of Circulating Tumour Cells in Prostate Cancer: From Bench to Bedside and Back.
Int J Mol Sci
; 17(9)2016 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-27657044
5.
Impact of concurrent tumour events on the prostate cancer outcomes of germline BRCA2 mutation carriers.
Eur J Cancer
; 185: 105-118, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36972661
6.
A logistic model for the detection of circulating tumour cells in human metastatic colorectal cancer.
J Cell Mol Med
; 16(10): 2342-9, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22304365
7.
Methylphenidate in the management of asthenia in breast cancer patients treated with docetaxel: results of a pilot study.
Invest New Drugs
; 30(2): 688-94, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20844926
8.
Exploring the synergistic effects of cabozantinib and a programmed cell death protein 1 inhibitor in metastatic renal cell carcinoma with machine learning.
Oncotarget
; 13: 237-256, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35106125
9.
Clinical Factors Associated With Long-Term Benefit in Patients With Metastatic Renal Cell Carcinoma Treated With Axitinib: Real-World AXILONG Study.
Clin Genitourin Cancer
; 20(1): 25-34, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34789409
10.
Epithelial-to-Mesenchymal Transition Mediates Resistance to Maintenance Therapy with Vinflunine in Advanced Urothelial Cell Carcinoma.
Cancers (Basel)
; 13(24)2021 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34944855
11.
Longitudinal CTCs gene expression analysis on metastatic castration-resistant prostate cancer patients treated with docetaxel reveals new potential prognosis markers.
Clin Exp Metastasis
; 38(2): 239-251, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33635497
12.
Clinical potential of circulating free DNA and circulating tumour cells in patients with metastatic non-small-cell lung cancer treated with pembrolizumab.
Mol Oncol
; 15(11): 2923-2940, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34465006
13.
Expert recommendations on the management of patients with metastatic castration-resistant prostate cancer who progress after CHAARTED or LATITUDE.
Ther Adv Med Oncol
; 12: 1758835920920067, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33014145
14.
Efficacy and toxicity of adjuvant chemotherapy on colorectal cancer patients: how much influence from the genetics?
J Chemother
; 32(6): 310-322, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32441565
15.
Global Gene Expression Characterization of Circulating Tumor Cells in Metastasic Castration-Resistant Prostate Cancer Patients.
J Clin Med
; 9(7)2020 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32630240
16.
Pazopanib: Evidence review and clinical practice in the management of advanced renal cell carcinoma.
BMC Pharmacol Toxicol
; 19(1): 77, 2018 Nov 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-30477570
17.
Improving circulating tumor cells enumeration and characterization to predict outcome in first line chemotherapy mCRPC patients.
Oncotarget
; 8(33): 54708-54721, 2017 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28903376
18.
Weekly cabazitaxel plus prednisone is effective and less toxic for 'unfit' metastatic castration-resistant prostate cancer: Phase II Spanish Oncology Genitourinary Group (SOGUG) trial.
Eur J Cancer
; 87: 30-37, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29102858
19.
A Prospective Observational Study for Assessment and Outcome Association of Circulating Endothelial Cells in Clear Cell Renal Cell Carcinoma Patients Who Show Initial Benefit from First-line Treatment. The CIRCLES (CIRCuLating Endothelial cellS) Study (SOGUG-CEC-2011-01).
Eur Urol Focus
; 3(4-5): 430-436, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28753791
20.
Long-term Response to Nivolumab and Acute Renal Failure in a Patient with Metastatic Papillary Renal Cell Carcinoma and a PD-L1 Tumor Expression Increased with Sunitinib Therapy: A Case Report.
Front Oncol
; 6: 250, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27921007